Ionis Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	372.26	242.08	399.27	276.47	869.19
Short-Term Investments	2,305	2,056	1,932	1,710	1,246
Cash & Short-Term Investments	2,677	2,298	2,331	1,987	2,115
Cash Growth	16.53%	-1.44%	17.33%	-6.06%	11.76%
Accounts Receivable	66.06	92.19	97.78	25.54	61.9
Inventory	10.05	12.51	7.44	22.03	24.81
Other Current Assets	237.09	217.93	205.43	168.25	143.37
Total Current Assets	2,991	2,620	2,642	2,203	2,345
Net Property, Plant & Equipment	361.6	256.11	242.94	255.84	196.04
Other Long-Term Assets	171.6	127.28	105.28	75.34	70.6
Total Assets	3,524	3,004	2,990	2,534	2,612
Accounts Payable	28.08	42.96	26.03	17.92	11.9
Accrued Expenses	222.33	178.05	215.62	189.28	127.37
Current Portion of Long-Term Debt	431.95	-	44.33	-	-
Unearned Revenue	73.76	78.99	151.13	90.58	97.71
Other Current Liabilities	25.45	9.31	10.98	13.78	3.56
Total Current Liabilities	781.57	309.32	448.09	311.56	240.55
Long-Term Debt	1,347	1,245	1,230	1,183	1,228
Long-Term Leases	262.38	161.81	170.88	178.94	19.43
Other Long-Term Liabilities	643.35	698.72	754.92	287.77	351.88
Total Long-Term Liabilities	2,253	2,106	2,155	1,649	1,599
Total Liabilities	3,035	2,415	2,603	1,961	1,840
Common Stock	0.16	0.16	0	0	0.14
Additional Paid-in Capital	3,145	2,869	2,215	2,060	1,964
Accumulated Other Comprehensive Income	-25.28	-30.81	-32.65	-57.48	-32.67
Retained Earnings	-2,631	-2,250	-1,796	-1,430	-1,160
Total Common Shareholders' Equity	489.09	588.35	386.54	572.75	771.74
Shareholders' Equity	489.09	588.35	386.69	572.89	771.74
Total Liabilities & Equity	3,524	3,004	2,990	2,534	2,612
Total Debt	2,042	1,407	1,445	1,362	1,248
Net Cash (Debt)	635.66	890.37	886.49	625.21	867.45
Net Cash Growth	-28.61%	0.44%	41.79%	-27.93%	-8.95%
Net Cash Per Share	3.97	5.96	6.19	4.41	6.15
Book Value	489.09	588.35	386.54	572.75	771.74
Book Value Per Share	3.06	3.94	2.70	4.04	5.47
Tangible Book Value	489.09	588.35	386.54	572.75	771.74
Tangible Book Value Per Share	3.06	3.94	2.70	4.04	5.47

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.